<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348384</url>
  </required_header>
  <id_info>
    <org_study_id>PRO14080588</org_study_id>
    <secondary_id>R01DA026472</secondary_id>
    <nct_id>NCT03348384</nct_id>
  </id_info>
  <brief_title>[11C]NOP-1A and Cocaine Use Disorders</brief_title>
  <official_title>Linking Nociceptive Opioid Peptide (NOP) Receptors With Relapse in Cocaine Use Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to compared [C-11]NOP-1A binding in recently abstinent cocaine use
      disorders and controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will allow for understanding brain stress and anti-stress mechanisms that underlie abuse
      of cocaine in humans.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>[C-11]NOP-1A</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>[C-11]NOP-1A VT</measure>
    <time_frame>Baseline</time_frame>
    <description>VT-volume of distribution expressed relative to total plasma</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cocaine Use Disorder</condition>
  <arm_group>
    <arm_group_label>Cocaine use disorders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PET scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PET scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>[C-11]</intervention_name>
    <description>Radiolabel</description>
    <arm_group_label>Cocaine use disorders</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NOP-1A</intervention_name>
    <description>Tracer</description>
    <arm_group_label>Cocaine use disorders</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        [A]Cocaine use disorders

        Inclusion criteria:

          1. Males or Females 18-50

          2. Fulfill DSM-5 Diagnosis for Cocaine use disorder

          3. Medically Healthy

        Major exclusion criteria:

          1. Pregnancy or lactation

          2. Comorbid medical, psychiatric, drug use disorders (other than cocaine, tobacco use,
             and recreational marijuana/alcohol use)

          3. Metal implants or paramagnetic objects contained within the body which may interfere
             with the MRI scan

          4. Currently employed as radiation worker; or participation in radioactive drug research
             protocols within the previous year

          5. Currently on any psychotropic medications that can influence nociceptin transmission
             in the brain (e.g., morphine, suboxone, SSRIs, etc.)

        [B] Healthy controls

        Inclusion criteria:

          1. Males or Females 18-50

          2. Absence of present or past psychiatric conditions (including alcohol or drug use
             disorders)

          3. A negative urine drug screen

          4. Medically Healthy

        Major exclusion criteria

          1. Pregnancy or lactation

          2. Medical, psychiatric or drug &amp; alcohol use disorders

          3. Metal implants or paramagnetic objects contained within the body which may interfere
             with the MRI scan

          4. Currently employed as radiation worker; or participation in radioactive drug research
             protocols within the previous year

          5. Currently on any psychotropic medications that can influence nociceptin transmission
             in the brain

          6. Family history of a psychotic disorder, manic episode, drug use disorders in
             first-degree relatives.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rajesh Narendran, MD</last_name>
    <email>narendranr@upmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajesh Narendran</last_name>
      <email>narendranr@upmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>November 17, 2017</last_update_submitted>
  <last_update_submitted_qc>November 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Rajesh Narendran</investigator_full_name>
    <investigator_title>Visiting Professor in Radiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

